Herpesvirus latency confers symbiotic protection from bacterial infection (original) (raw)

References

1. Rickinson, A. B. & Kieff, E. Fields Virology (eds Knipe, D. M. & Howley, P.) 2655– 2670 (Lippincott-Raven, Philadelphia, 2007)
   Google Scholar
2. Virgin, H. W. et al. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71, 5894– 5904 (1997)
   CAS PubMed PubMed Central Google Scholar
3. McClellan, K. B., Gangappa, S., Speck, S. H. & Virgin, H. W. Antibody-independent control of gamma-herpesvirus latency via B cell induction of anti-viral T cell responses. PLoS Pathog. 2, e58 (2006)
   Article Google Scholar
4. Weck, K. E., Kim, S. S., Virgin, H. W. & Speck, S. H. Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J. Virol. 73, 3273– 3283 (1999)
   CAS PubMed PubMed Central Google Scholar
5. Edelson, B. T. & Unanue, E. R. Immunity to Listeria infection. Curr. Opin. Immunol. 12, 425– 431 (2000)
   Article CAS Google Scholar
6. Moorman, N. J., Willer, D. O. & Speck, S. H. The gammaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency. J. Virol. 77, 10295– 10303 (2003)
   Article CAS Google Scholar
7. Cathelyn, J. S., Crosby, S. D., Lathem, W. W., Goldman, W. E. & Miller, V. L. RovA, a global regulator of Yersinia pestis, specifically required for bubonic plague. Proc. Natl Acad. Sci. USA 103, 13514– 13519 (2006)
   Article ADS CAS Google Scholar
8. Braaten, D. C. et al. Effective control of chronic gamma-herpesvirus infection by unconventional MHC Class Ia-independent CD8 T cells. PLoS Pathog. 2, e37 (2006)
   Article Google Scholar
9. Sarawar, S. R. et al. Gamma interferon is not essential for recovery from acute infection with murine gammaherpesvirus 68. J. Virol. 71, 3916– 3921 (1997)
   CAS PubMed PubMed Central Google Scholar
10. Tibbetts, S. A., Van Dyk, L., Speck, S. H. & Virgin, H. W. Immune control of the number and reactivation phenotype of cells latently infected with a gamma-herpesvirus. J. Virol. 76, 7125– 7132 (2002)
    Article CAS Google Scholar
11. Christensen, J. P. & Doherty, P. C. Quantitative analysis of the acute and long-term CD4+ T-cell response to a persistent gammaherpesvirus. J. Virol. 73, 4279– 4283 (1999)
    CAS PubMed PubMed Central Google Scholar
12. Flano, E., Woodland, D. L., Blackman, M. A. & Doherty, P. C. Analysis of virus-specific CD4+ T cells during long-term gammaherpesvirus infection. J. Virol. 75, 7744– 7748 (2001)
    Article CAS Google Scholar
13. Polic, B. et al. Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J. Exp. Med. 188, 1047– 1054 (1998)
    Article CAS Google Scholar
14. Mackaness, G. B. The immunological basis of acquired cellular resistance. J. Exp. Med. 120, 105– 120 (1964)
    Article CAS Google Scholar
15. Mackaness, G. B. The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J. Exp. Med. 129, 973– 992 (1969)
    Article CAS Google Scholar
16. Selin, L. K. et al. Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity. Immunol. Rev. 211, 164– 181 (2006)
    Article CAS Google Scholar
17. Berg, R. E., Crossley, E., Murray, S. & Forman, J. Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen. J. Exp. Med. 198, 1583– 1593 (2003)
    Article CAS Google Scholar
18. Tan, L. C. et al. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J. Immunol. 162, 1827– 1835 (1999)
    CAS PubMed Google Scholar
19. Dunn, H. S. et al. Dynamics of CD4 and CD8 T cell responses to cytomegalovirus in healthy human donors. J. Infect. Dis. 186, 15– 22 (2002)
    Article CAS Google Scholar
20. Amyes, E. et al. Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection. J. Exp. Med. 198, 903– 911 (2003)
    Article CAS Google Scholar
21. Hislop, A. D. et al. Tonsillar homing of Epstein-Barr virus-specific CD8+ T cells and the virus-host balance. J. Clin. Invest. 115, 2546– 2555 (2005)
    Article CAS Google Scholar
22. Theil, D. et al. Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am. J. Pathol. 163, 2179– 2184 (2003)
    Article CAS Google Scholar
23. Balkwill, F. & Mantovani, A. Inflammation and cancer: back to Virchow? Lancet 357, 539– 545 (2001)
    Article CAS Google Scholar
24. Schaub, B., Lauener, R. & von Mutius, E. The many faces of the hygiene hypothesis. J. Allergy Clin. Immunol. 117, 969– 977 (2006)
    Article Google Scholar
25. Takeuchi, K. et al. Prevalence of Epstein-Barr virus in Japan: trends and future prediction. Pathol. Int. 56, 112– 116 (2006)
    Article Google Scholar
26. Nilsson, C. et al. Does early EBV infection protect against IgE sensitization? J. Allergy Clin. Immunol. 116, 438– 444 (2005)
    Article CAS Google Scholar
27. Roizman, B. & Pellett, P. E. Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2475– 2499 (Lippincott-Raven, Philadelphia, 2007)
    Google Scholar
28. Shrestha, B. et al. Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J. Virol. 80, 5338– 5348 (2006)
    Article CAS Google Scholar
29. McClellan, J. S., Tibbetts, S. A., Gangappa, S., Brett, K. A. & Virgin, H. W. Critical role of CD4 T cells in an antibody-independent mechanism of vaccination against gamma-herpesvirus latency. J. Virol. 78, 6836– 6845 (2004)
    Article CAS Google Scholar
30. Edelson, B. T. & Unanue, E. R. Intracellular antibody neutralizes Listeria growth. Immunity 14, 503– 512 (2001)
    Article CAS Google Scholar

Download references